Skip to main content
Log in

Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The intracisternal administration of 5,7-dihydroxytryptamine (5,7-DHT) to rats resulted in a potentiated response to 5-hydroxytryptophan (5-HTP) when the animals were tested 30 days later. The 5-HTP-induced changes include elevation of serum prolactin decrease in operant responding, and the magnitude of the “serotonin behavioral syndrome” observed after 5-HTP administration. The serotonin concentration in brains of 5,7-DHT-treated animals reached maximum earlier and remained elevated longer than that of controls following administration of 5-HTP. Brain norepinephrine and dopamine concentration were not affected by 5-HTP in either group of animals. The increase in serum prolactin concentration elicited by administration of the serotonergic agonists quipazine or 5-methyxy-N,N-dimethyltryptamine and by the serotonin uptake inhibitor fenfluramine also was potentiated by pretreating rats with 5,7-DHT. These data suggest that both serotonergic receptor supersensitivity and the absence of presynaptic uptake sites contribute to the enhanced responses to 5-HTP occurring in rats previously treated with 5,7-DHT. The findings further demonstrate that both behavioral and hormonal measures can be used to assess the sensitivity of serotonergic receptors and indicate that 5,7-DHT may be useful in evaluating the role of serotonergic neurons in neuroendocrine function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Advis JP, Simpkins JW, Meites J (1979) Serotonergic control of prolactin release in male rats Life Sci 24:359–366

    Google Scholar 

  • Baumgarten HG, Lachenmayer L (1972) 5,7-Dihydroxytryptamine: Improvement in chemical lesioning of indoleamine neurons in the mammalian brain. Z Mikroscop Anat Forsch 135:399–414

    Google Scholar 

  • Baumgarten HG, Bjorklund A, Sachenmayer L, Nobin A (1973) Evaluation of the effects of 5,7-dihydroxytryptamine on serotonin and catecholamine neurons in the rat CNS. Acta Physiol Scand (Suppl) 391:1–19

    Google Scholar 

  • Bogdanski DR, Pletscher A, Brodie BB, Udenfriend S (1956) Identification and assay of serotonin in brain. J Pharmacol Exp Ther 117:82–88

    Google Scholar 

  • Breese GR, Cooper BR (1975) Behavioral and biochemical interactions of 5,7-dihydroxytryptamine with various drugs, when administered intracisternally to adult and developing rats. Brain Res 98:517–527

    Google Scholar 

  • Breese GR, Mueller RA (1978) Alterations in the neurocytotoxicity of 5,7-dihydroxytryptamine by pharmacological agents in adult and developing rats. Ann NY Acad Sci 305:160–174

    Google Scholar 

  • Breese GR, Traylor TD (1970) Effect of 6-hydroxydopamine on brain norepinephrine and dopamine: Evidence for selective degeneration of catecholamine neurons. J Pharmacol Exp Ther 174:413–420

    Google Scholar 

  • Breese GR, Vogel RA, Kuhn CM, Mailman RB, Mueller RA, Schanberg SM (1978) Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine. Brain Res 155:263–275

    Google Scholar 

  • Brodie BB, Comer MS, Costa E, Dlabac A (1966) The role of brain serotonin in the mechanism of the central action of reserpine. J Pharmacol Exp Ther 152:340–349

    Google Scholar 

  • Butcher LL, Engel J, Fuxe K (1972) Behavioral, biochemical and histochemical analysis after peripheral decarboxylase inhibition. Brain Res 41:387–411

    Google Scholar 

  • Chen HG, Meites G (1975) Effects of biogenic amines and TRH on release of prolactin and TSH in the rat. Endocrinology 96:10–14

    Google Scholar 

  • Clemens JA (1978) Effects of serotonin neurotoxins on pituitary hormone release. Ann NY Acad Sci 305:399–410

    Google Scholar 

  • Clemens JA, Sawyer BD, Cerimele B (1977) Further evidence that serotonin in a neurotransmitter involved in the control of prolactin secretion. Endocronilogy 100:692–698

    Google Scholar 

  • Costa E, Groppetti A, Revuelta A (1971) Action of fenfluramine on monoamine stores of rat tissue. Br J Pharmacol 41:57–64

    Google Scholar 

  • Daly J, Fuxe K, Jonsson J (1974) 5,7-Dihydroxytryptamine as a tool for the morphological and functional analysis of central 5-hydryxytryptamine neurons. Res Commun Chem Pathol Pharmacol 7:175–187

    Google Scholar 

  • Dickerman S, Kledzik G, Gelato M, Chen HJ, Meites J (1974) Effects of haloperidol on serum and pituitary prolactin, LH, FSH, and hypothalamic PIF and LRF. Neuroendocrinology 15:10–20

    Google Scholar 

  • Fessler RG, Meltzer HY (1979) Effect of electrolytic lesions of the medial raphe nucleus on 5-HTP and LU10-171 induced increases in serum prolactin levels in rats. Neurosci Abstr 1563, vol 5

  • Fuller RW, Perry KW, Clemens JA (1976) Elevation of 3,4-dihydroxyphenylacetic acid concentrations in rat brain and stimulation of prolactin secretion by fenfluramine: Evidence for antagonism at dopamine receptor sites. J Pharm Pharmacol 28:643–644

    Google Scholar 

  • Fuxe K, Holmstedt B, Jonsson J (1972) Effects of 5-methoxy-N,N-dimethyltryptamine on central monoamine neurons. Eur J Pharmacol 19:25–34

    Google Scholar 

  • Gerson S, Baldessarini RJ (1975) Selective destruction of serotonin terminals in rat forebrain by high doses of 5,7-dihydroxytryptamine. Brain Res 85:140–145

    Google Scholar 

  • Gil-Ad I, Zambotti F, Carruba MO, Vicentini L, Muller EE (1976) Stimulatory role for brain serotonergic system in prolactin secretion in the male rat. Proc Soc Exp Biol Med 151:512–518

    Google Scholar 

  • Hole K, Fuxe K, Jonsson G (1976) Behavioral effects of 5,7-dihydroxytryptamine lesions of ascending 5-hydroxytryptamine pathways. Brain Res 107:385–399

    Google Scholar 

  • Honig E, Sancilio RL, Vargas R, Pardo EG (1969) Similarities between the pharmacological actions of quipazine and serotonin. Eur J Pharmacol 6:274–280

    Google Scholar 

  • Hunter WM, Greenwood FC (1962) Preparation of iodine-131-labelled human growth hormone on high specific activity. Nature 194:495–496

    Google Scholar 

  • Kamberi IA, Mical RA, Porter JC (1971) Effects of melatonin and serotonin on the release of FSH and prolactin. Endocrinology 88:1288–1293

    Google Scholar 

  • Kizer JS, Zivin JA, Jacobowitz DM, Kopin IJ (1975) The nyctohemeral rhythm of plasma prolactin: Effects of ganglionectomy, pinealectomy, constant light, constant darkness or 6-OH-dopamine administration. Endocrinology 96:1230–1240

    Google Scholar 

  • Knapp S, Mandell AJ (1976) Coincidence of blockade of synaptosomal 5-hydroxytryptamine uptake and decrease in tryptophan hydroxylase activity: Effect of fenfluramine. J Pharmacol Expl Ther 198:123–132

    Google Scholar 

  • Kordon C, Blake J, Sawyer CH (1973) Participation of serotonincontaining neurons in the suckling-induced rise in plasma prolactin levels in lactating rats. Neuroendocrinology 13:213–223

    Google Scholar 

  • Krulich L (1975) The effect of a serotonin uptake inhibitor (Lilly 110140) on the secretion of prolactin in the rat. Life Sci 17:1141–1144

    Google Scholar 

  • Lawson DM, Gala RR (1973) The influence of adrenergic, dopaminergic, cholinergic and serotonergic drugs on plasma prolactin levels in ovariecotomized estrogen-treated rats. Endocrinology 96:152–155

    Google Scholar 

  • Lorens SA, Guldberg HC, Hole K, Kohler C, Srebro B (1979) Activity, avoidance learning and regional 5-hydroxytyrptamine following intra-brainstem 5,7-dihydroxytryptamine and electrolytic midbrain raphe lesions in the rat. Brain Res 108:97–113

    Google Scholar 

  • Lu KH, Meites J (1973) Effects of serotonin precursors and melatonin on serum prolactin release in rats. Endocrinology 93:152–155

    Google Scholar 

  • McLeod RM Lamberts SWJ (1978) Regulation of prolactin secretion by dopamine and serotonin related drugs. In: Robyn C, Harter M (eds) Progress in prolactin physiology and pathology, Elsevier, New York, pp 111–116

    Google Scholar 

  • Meltzer HY, Fang VS, Paul SM, Kaluskar R (1976) Effect of quipazine on rat plasma prolactin levels. Life Sci 19:1073–1078

    Google Scholar 

  • Meltzer HY, Fessler RG, Simonovich M, Fang VS (1977) Effect of indole hallucinogens, mescaline and DMPEA on rat plasma prolactin. Fed Proc 36:984

    Google Scholar 

  • Morgan WW, Herbert DC (1978) Elevation of serum prolactin levels after the inhibition of serotonin uptake. Endocrinology 103:1016–1022

    Google Scholar 

  • Nelson DL, Herbert A, Bourgoing S, Glowinski J, Hamon M (1978) Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihyroxytryptamine administration in the rat. Mol Pharmacol 14:963–995

    Google Scholar 

  • Ng LKY, Chase TN, Colburn RW, Kopin IJ (1972) Release of 3H-dopamine by l-5-hydroxytryptophan. Brain Res 45:499–505

    Google Scholar 

  • Ohgo S, Kato Y, Chihara K, Imura H, Maeda K (1976) Effect of hypothalamic surgery on prolactin release induced by 5-hydroxytryptophan (5-HTP) in rats. Endocrinol J 23:485–491

    Google Scholar 

  • Ojeda SR, Harms PG, McCann SM (1976) Effect of blockade of dopaminergic receptors on prolactin and LH release: Median eminence and pituitary sites of action. Endocrinology 94:1650–1657

    Google Scholar 

  • Rodriguez R, Rojos Ramirez J, Drucker-Colin R (1973) Serotonin-like actions of quipazine on the central nervous system. Eur J Pharmacol 24:164–171

    Google Scholar 

  • Smith JE, Lane JD, Shea PA, McBride WJ (1977) Neurochemical changes following administration of precursor of biogenic amines. Life Sci 21:301–306

    Google Scholar 

  • Stewart RM, Growdon JH, Cancian D, Baldessarini RJ (1976) 5-Hydroxytryptophan-induced myoclonus: Increased sensitivity to serotonin after intracranial 5,7-dihydroxytryptamine in the adult rat. Neuropharmacology 15:449–455

    Google Scholar 

  • Subramania MG, Gala RR (1976) The influence of cholinergic, adrenergic and serotonergic drugs on the afternoon surge of plasma prolactin in ovariectomized estrogen-treated rats. Endocrinology 98:842–848

    Google Scholar 

  • Trulson ME, Eubanks EE, Jacobs BL (1976) Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine. J Pharmacol Expl Ther 198:23–32

    Google Scholar 

  • Winter JC (1969) Behavioral effects of N,N-diethyltryptamine: Absence of antagonism by xylamidine tosylate. J Pharmacol Exp Ther 169:7–16

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuhn, C.M., Vogel, R.A., Mailman, R.B. et al. Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats. Psychopharmacology 73, 188–193 (1981). https://doi.org/10.1007/BF00429216

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00429216

Key words

Navigation